Targeting Inflammation and Gut Microbiota with Antibacterial Therapy: Implications for Central Nervous System Health DOI
Jing Wei,

Chunmeng Liu,

Dalian Qin

et al.

Ageing Research Reviews, Journal Year: 2024, Volume and Issue: unknown, P. 102544 - 102544

Published: Oct. 1, 2024

Language: Английский

A review on probiotics and dietary bioactives: Insights on metabolic well-being, gut microbiota, and inflammatory responses DOI Creative Commons
Alice Njolke Mafe, Great Iruoghene Edo,

Osamah S. Majeed

et al.

Food Chemistry Advances, Journal Year: 2025, Volume and Issue: 6, P. 100919 - 100919

Published: Feb. 11, 2025

Language: Английский

Citations

4

The interplay of gut microbiota, obesity, and depression: insights and interventions DOI Creative Commons
Iryna Halabitska, Pavlo Petakh, Iryna Kamyshna

et al.

Cellular and Molecular Life Sciences, Journal Year: 2024, Volume and Issue: 81(1)

Published: Oct. 30, 2024

Language: Английский

Citations

9

Cariogenic Microbiota and Emerging Antibacterial Materials to Combat Dental Caries: A Literature Review DOI Creative Commons
Jingwei Cao, Qizhao Ma, Jia Shi

et al.

Pathogens, Journal Year: 2025, Volume and Issue: 14(2), P. 111 - 111

Published: Jan. 23, 2025

Dental caries is the most common oral disease in world and a chronic infectious disease. The cariogenic microbiome plays an important role process of caries. ecological imbalance microbiota leads to low pH, which causes Therefore, antibacterial materials have always been hot topic. Traditional such as cationic agents, metal ion some natural extract agents good effects. However, they can cause bacterial resistance poor biological safety when used for long-term purposes. Intelligent materials, pH-responsive nanozymes, photoresponsive piezoelectric living are emerging nano-strategies that respond microenvironment or other specific stimuli exert Compared with traditional these less prone resistanceand safety. This review summarizes characteristics materials. These accurately act on microenvironment, showing intelligent effects providing new ideas management.

Language: Английский

Citations

1

Dysbiosis and extraintestinal cancers DOI Creative Commons
Rui He,

Ping-Qian Qi,

Lin-Zhen Shu

et al.

Journal of Experimental & Clinical Cancer Research, Journal Year: 2025, Volume and Issue: 44(1)

Published: Feb. 7, 2025

Abstract The gut microbiota plays a crucial role in safeguarding host health and driving the progression of intestinal diseases. Despite recent advances remarkable correlation between dysbiosis extraintestinal cancers, underlying mechanisms are yet to be fully elucidated. Pathogenic microbiota, along with their metabolites, can undermine integrity barrier through inflammatory or metabolic pathways, leading increased permeability translocation pathogens. dissemination pathogens circulation may contribute establishment an immune-suppressive environment that promotes carcinogenesis organs either directly indirectly. oncogenic cascade always engages disruption hormonal regulation responses, induction genomic instability mutations, dysregulation adult stem cell proliferation. This review aims comprehensively summarize existing evidence points potential malignant transformation such as liver, breast, lung, pancreas. Additionally, we delve into limitations inherent current methodologies, particularly challenges associated differentiating low loads gut-derived microbiome within tumors from sample contamination symbiotic microorganisms. Although still controversial, understanding contribution translocated metabolites pathological continuum chronic inflammation could offer novel foundation for development targeted therapeutics.

Language: Английский

Citations

1

Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications DOI
Abhishek Satheesan, Janardanan Kumar,

K.V. Leela

et al.

Inflammopharmacology, Journal Year: 2024, Volume and Issue: 32(5), P. 2753 - 2779

Published: Aug. 19, 2024

Language: Английский

Citations

6

Farmasi Cerdas: Era Baru Penemuan Obat dengan AI dan Big Data DOI Creative Commons
Raymond R. Tjandrawinata

MEDICINUS, Journal Year: 2025, Volume and Issue: 38(1), P. 27 - 36

Published: Jan. 1, 2025

Proses penemuan obat telah memasuki era baru dengan munculnya kecerdasan buatan (artificial intelligence/AI) dan big data. Pendekatan tradisional, panjang, mahal kini dilengkapi alternatif yang efisien berkat kemampuan AI untuk menganalisis pola kompleks data mengintegrasikan kumpulan berskala besar. Artikel ini membahas peran teknologi tersebut dalam mempercepat inovasi farmasi, mengulas aplikasi praktis, menyoroti tantangan serta prospek masa depan. Dengan data, industri farmasi dapat memajukan pengobatan presisi memperdalam pemahaman kita tentang biologi penyakit.

Citations

0

Environmental antibiotic emissions and their residual impact on livestock farming DOI

Junhun Kweon,

Hojun Lee, Seung Wook Kim

et al.

Molecular & Cellular Toxicology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 21, 2025

Language: Английский

Citations

0

Microbiome and Brain-Gut Microbiota's Influence on Autism Pathogenesis DOI
Aman B. Upaganlawar, Nitu L. Wankhede, Mayur B. Kale

et al.

IGI Global eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 99 - 132

Published: Jan. 31, 2025

Autism Spectrum Disorders (ASD) are neurodevelopmental conditions characterized by social communication challenges and repetitive behaviors. Emerging evidence suggests that gut microbiota, through the gut-brain axis, play a significant role in ASD pathogenesis. This complex network influences neurodevelopment modulating immune responses, producing neuroactive metabolites, maintaining barrier integrity. In individuals with ASD, specific microbial imbalances reduced diversity commonly observed, which linked to these pathophysiological processes. Genetic predispositions environmental factors, such as diet antibiotic use, further affect microbiota composition, potentially exacerbating imbalances. Therapeutic strategies targeting including probiotics, prebiotics, dietary modifications, fecal transplantation, have shown potential alleviating symptoms. chapter provides comprehensive overview of current understanding microbiota's ASD.

Language: Английский

Citations

0

Failure or future? Exploring alternative antibacterials: a comparative analysis of antibiotics and naturally derived biopolymers DOI Creative Commons
Artemijs Ščeglovs, Ingus Skadiņš, Marco Chittò

et al.

Frontiers in Microbiology, Journal Year: 2025, Volume and Issue: 16

Published: Feb. 3, 2025

The global crisis of antimicrobial resistance (AMR) is escalating due to the misuse and overuse antibiotics, slow development new therapies, rise multidrug-resistant (MDR) infections. Traditional antibiotic treatments face limitations, including resistance, disruption microbiota, adverse side effects, environmental impact, emphasizing urgent need for innovative alternative antibacterial strategies. This review critically examines naturally derived biopolymers with intrinsic (essential feature) properties as a sustainable, next-generation traditional antibiotics. These may address bacterial uniquely by disrupting membranes rather than cellular functions, potentially reducing microbiota interference. Through comparative analysis mechanisms applications antibiotics biopolymers, this highlights potential such AMR while supporting human health.

Language: Английский

Citations

0

The Gut Virome and Human Health: From Diversity to Personalized Medicine DOI Creative Commons

Rahul Harikumar Lathakumari,

K.V. Leela,

Anusha Gopinathan

et al.

Engineering Microbiology, Journal Year: 2025, Volume and Issue: unknown, P. 100191 - 100191

Published: Feb. 1, 2025

Language: Английский

Citations

0